Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...
Hosted on MSN1mon
Globus Medical strengthens SCS market position with $250m Nevro dealBoston Scientific’s Wavewriter spinal cord stimulator systems, for example, gained access to a wider market after winning FDA approval for non-surgical back pain in February 2024. Looking ahead ...
Cohen notably served as CEO and a member of the board at Axonics, a company he co-founded in 2013 and took public in 2018. A ...
Boston Scientific Co. (NYSE:BSX – Get Free Report) has been assigned an average recommendation of “Buy” from the twenty-three research firms that are presently covering the stock, MarketBeat.com ...
Madison Investment Advisors LLC purchased a new position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results